March 2023

Includes: Prostate Cancer ADT Increases Bone Fracture Risk, Testosterone Therapy, Improving Survival in Black Patients, Advanced Prostate Cancer on the rise, Cal Ripken Jr. on PC, and more!

Prostate Cancer Patient Empowerment Program

Drs. Gabriela Ilie and Rob Rutledge from Dalhousie University out of Halifax join us to discuss their exciting research initiative that looks to help prostate cancer survivors empower themselves to take better care of themselves and benefit from their shared experiences. Learn more at their website http://pcpep.org

Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer

PROSTAID Calgary’s 2022 Pathfinder Award went to Dr. Geoffrey Gotto, who presented on new research and innovations in metastatic castration-sensitive prostate cancer (MCSPC) that is leading to longer survival and greater quality of life in prostate cancer patients who do combinations of treatments to combat the cancer.